Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

Authors

Keywords:

Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of

Abstract

Omalizumab is a safe and effective treatment option for chronic spontaneous urticaria (CSU). Although cohort studies in patients with asthma show no increased risk of congenital abnormalities, very little data exist in the literature regarding the use of omalizumab for CSU during pregnancy. Herein, the safe and successful use of omalizumab updosing in a pregnant woman with CSU along with a review of the published literature is presented.

Downloads

Download data is not yet available.

Downloads

Published

2021-08-20

How to Cite

1.
Salman A, Aktaş M. Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature. AAI [Internet]. 2021 Aug. 20 [cited 2021 Dec. 2];19(2):114-7. Available from: https://aai.org.tr/index.php/aai/article/view/599

Issue

Section

Case Reports